Patel, J.R.; Banjara, B.; Ohemeng, A.; Davidson, A.M.; Boué, S.M.; Burow, M.E.; Tilghman, S.L.
Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1. Nutrients 2023, 15, 1632.
https://doi.org/10.3390/nu15071632
AMA Style
Patel JR, Banjara B, Ohemeng A, Davidson AM, Boué SM, Burow ME, Tilghman SL.
Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1. Nutrients. 2023; 15(7):1632.
https://doi.org/10.3390/nu15071632
Chicago/Turabian Style
Patel, Jankiben R., Bipika Banjara, Afia Ohemeng, A. Michael Davidson, Stephen M. Boué, Matthew E. Burow, and Syreeta L. Tilghman.
2023. "Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1" Nutrients 15, no. 7: 1632.
https://doi.org/10.3390/nu15071632
APA Style
Patel, J. R., Banjara, B., Ohemeng, A., Davidson, A. M., Boué, S. M., Burow, M. E., & Tilghman, S. L.
(2023). Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1. Nutrients, 15(7), 1632.
https://doi.org/10.3390/nu15071632